Large-scale testing (Phase 3)Active Not RecruitingNCT06134362
What this trial is testing
Long-term Follow-up of Long-acting Cabotegravir (CAB LA) for PrEP (Pre-exposure Prophylaxis) in Participants at Risk of Acquiring HIV (Human Immunodeficiency Virus)
Who this might be right for
HIV Infections
ViiV Healthcare 2,996